{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:59:35Z","timestamp":1794027575604,"version":"4.8.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["K01HL159038-01A1"],"award-info":[{"award-number":["K01HL159038-01A1"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["R25HL146166"],"award-info":[{"award-number":["R25HL146166"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["24CDA1269532"],"award-info":[{"award-number":["24CDA1269532"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001465","name":"American Thoracic Society","doi-asserted-by":"publisher","award":["23-24U1"],"award-info":[{"award-number":["23-24U1"]}],"id":[{"id":"10.13039\/100001465","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06709-7","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T10:28:59Z","timestamp":1750156139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Experimental animal models and patient-derived platforms to bridge preclinical discovery and translational therapeutics in pulmonary arterial hypertension"],"prefix":"10.1186","volume":"23","author":[{"given":"Elizabeth","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8826-4649","authenticated-orcid":false,"given":"Malik","family":"Bisserier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"issue":"25","key":"6709_CR1","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1056\/NEJMra2000348","volume":"385","author":"PM Hassoun","year":"2021","unstructured":"Hassoun PM. Pulmonary arterial hypertension. N Engl J Med. 2021;385(25):2361\u201376.","journal-title":"N Engl J Med"},{"key":"6709_CR2","doi-asserted-by":"crossref","unstructured":"Kularatne M, Gerges C, Jevnikar M, Humbert M, Montani D. Updated clinical classification and hemodynamic definitions of pulmonary hypertension and its clinical implications. J Cardiovasc Dev Dis. 2024;11(3).","DOI":"10.3390\/jcdd11030078"},{"key":"6709_CR3","doi-asserted-by":"crossref","unstructured":"Kovacs G, Bartolome S, Denton CP, Gatzoulis MA, Gu S, Khanna D, Badesch D, Montani D. Definition, classification and diagnosis of pulmonary hypertension. Eur Respir J. 2024;64(4).","DOI":"10.1183\/13993003.01324-2024"},{"issue":"3","key":"6709_CR4","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1152\/physrev.00030.2021","volume":"103","author":"A Balistrieri","year":"2023","unstructured":"Balistrieri A, Makino A, Yuan JX. Pathophysiology and pathogenic mechanisms of pulmonary hypertension: role of membrane receptors, ion channels, and Ca(2+) signaling. Physiol Rev. 2023;103(3):1827\u201397.","journal-title":"Physiol Rev"},{"key":"6709_CR5","doi-asserted-by":"publisher","first-page":"117954682412747","DOI":"10.1177\/11795468241274744","volume":"18","author":"M Namazi","year":"2024","unstructured":"Namazi M, Eftekhar SP, Mosaed R, Shiralizadeh Dini S, Hazrati E. Pulmonary hypertension and right ventricle: a pathophysiological insight. Clin Med Insights Cardiol. 2024;18:11795468241274744.","journal-title":"Clin Med Insights Cardiol"},{"issue":"1","key":"6709_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/s12967-023-04339-5","volume":"21","author":"J Dave","year":"2023","unstructured":"Dave J, Jagana V, Janostiak R, Bisserier M. Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development. J Transl Med. 2023;21(1):477.","journal-title":"J Transl Med"},{"key":"6709_CR7","doi-asserted-by":"crossref","unstructured":"Jia Z, Wang S, Yan H, Cao Y, Zhang X, Wang L, Zhang Z, Lin S, Wang X, Mao J. Pulmonary vascular remodeling in pulmonary hypertension. J Pers Med. 2023;13(2).","DOI":"10.3390\/jpm13020366"},{"key":"6709_CR8","doi-asserted-by":"crossref","unstructured":"Gomes MT, Bai Y, Potje SR, Zhang L, Lockett AD, Machado RF. Signal transduction during metabolic and inflammatory reprogramming in pulmonary vascular remodeling. Int J Mol Sci. 2022;23(5).","DOI":"10.3390\/ijms23052410"},{"issue":"2","key":"6709_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.31083\/j.rcm.2020.02.597","volume":"21","author":"M Bisserier","year":"2020","unstructured":"Bisserier M, Pradhan N, Hadri L. Current and emerging therapeutic approaches to pulmonary hypertension. Rev Cardiovasc Med. 2020;21(2):163\u201379.","journal-title":"Rev Cardiovasc Med"},{"issue":"1","key":"6709_CR10","doi-asserted-by":"publisher","first-page":"R17","DOI":"10.1530\/VB-19-0030","volume":"2","author":"M Bisserier","year":"2020","unstructured":"Bisserier M, Janostiak R, Lezoualc\u2019h F, Hadri L. Targeting epigenetic mechanisms as an emerging therapeutic strategy in pulmonary hypertension disease. Vasc Biol. 2020;2(1):R17\u201334.","journal-title":"Vasc Biol"},{"issue":"6","key":"6709_CR11","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.chest.2024.06.3824","volume":"166","author":"M Griffiths","year":"2024","unstructured":"Griffiths M, Simpson CE, Yang J, Vaidya D, Nies MK, Brandal S, Damico R, Hassoun P, Ivy DD, Austin ED, et al. Equivalency of multiple biomarkers to clinical pulmonary arterial hypertension survival risk models. Chest. 2024;166(6):1511\u201331.","journal-title":"Chest"},{"issue":"8","key":"6709_CR12","doi-asserted-by":"publisher","first-page":"e70008","DOI":"10.1002\/hsr2.70008","volume":"7","author":"M Aghaei","year":"2024","unstructured":"Aghaei M, Khademi R, Bahreiny SS, Saki N. The need to establish and recognize the field of clinical laboratory science (CLS) as an essential field in advancing clinical goals. Health Sci Rep. 2024;7(8):e70008.","journal-title":"Health Sci Rep"},{"issue":"9","key":"6709_CR13","doi-asserted-by":"publisher","first-page":"e70083","DOI":"10.1002\/hsr2.70083","volume":"7","author":"E Torfi","year":"2024","unstructured":"Torfi E, Bahreiny SS, Saki N, Khademi R, Sarbazjoda E, Nezhad IA, Aghaei M. Evaluation of Pro-BNP biomarker in heart failure patients and its relationship with complete blood count parameters: a case-control study. Health Sci Rep. 2024;7(9):e70083.","journal-title":"Health Sci Rep"},{"issue":"1","key":"6709_CR14","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12933-024-02441-6","volume":"23","author":"AK Rai","year":"2024","unstructured":"Rai AK, Muthukumaran NS, Nisini N, Lee T, Kyriazis ID, de Lucia C, Piedepalumbo M, Roy R, Uchida S, Drosatos K, et al. Transcriptome wide changes in long noncoding RNAs in diabetic ischemic heart disease. Cardiovasc Diabetol. 2024;23(1):365.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"6709_CR15","doi-asserted-by":"publisher","first-page":"e70191","DOI":"10.1002\/hsr2.70191","volume":"7","author":"M Torabizadeh","year":"2024","unstructured":"Torabizadeh M, Aghaei M, Saki N, Vahid MA, Bitaraf S, Bandar B. The association of nasal and blood eosinophils with serum IgE level in allergic rhinitis and asthma: a case-control study. Health Sci Rep. 2024;7(11):e70191.","journal-title":"Health Sci Rep"},{"issue":"5","key":"6709_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1164\/rccm.201607-1515PP","volume":"195","author":"S Bonnet","year":"2017","unstructured":"Bonnet S, Provencher S, Guignabert C, Perros F, Boucherat O, Schermuly RT, Hassoun PM, Rabinovitch M, Nicolls MR, Humbert M. Translating research into improved patient care in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2017;195(5):583\u201395.","journal-title":"Am J Respir Crit Care Med"},{"issue":"208","key":"6709_CR17","doi-asserted-by":"publisher","first-page":"208sr205","DOI":"10.1126\/scitranslmed.3005428","volume":"5","author":"G Sutendra","year":"2013","unstructured":"Sutendra G, Michelakis ED. Pulmonary arterial hypertension: challenges in translational research and a vision for change. Sci Transl Med. 2013;5(208):208sr205.","journal-title":"Sci Transl Med"},{"issue":"14","key":"6709_CR18","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1161\/CIRCULATIONAHA.106.673988","volume":"118","author":"ED Michelakis","year":"2008","unstructured":"Michelakis ED, Wilkins MR, Rabinovitch M. Emerging concepts and translational priorities in pulmonary arterial hypertension. Circulation. 2008;118(14):1486\u201395.","journal-title":"Circulation"},{"issue":"9","key":"6709_CR19","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1161\/CIRCRESAHA.121.319971","volume":"130","author":"O Boucherat","year":"2022","unstructured":"Boucherat O, Agrawal V, Lawrie A, Bonnet S. The latest in animal models of pulmonary hypertension and right ventricular failure. Circ Res. 2022;130(9):1466\u201386.","journal-title":"Circ Res"},{"issue":"1","key":"6709_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1086\/674886","volume":"4","author":"A Lawrie","year":"2014","unstructured":"Lawrie A. A report on the use of animal models and phenotyping methods in pulmonary hypertension research. Pulm Circ. 2014;4(1):2\u20139.","journal-title":"Pulm Circ"},{"key":"6709_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/978-1-0716-2707-5_20","volume":"2573","author":"M Bisserier","year":"2022","unstructured":"Bisserier M, Boucherat O, Bonnet S, Hadri L. Intra-airway gene delivery for pulmonary hypertension in rodent models. Methods Mol Biol. 2022;2573:263\u201378.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"6709_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.hrthm.2021.09.021","volume":"19","author":"B Strauss","year":"2022","unstructured":"Strauss B, Bisserier M, Obus E, Katz MG, Fargnoli A, Cacheux M, Akar JG, Hummel JP, Hadri L, Sassi Y, et al. Right predominant electrical remodeling in a pure model of pulmonary hypertension promotes reentrant arrhythmias. Heart Rhythm. 2022;19(1):113\u201324.","journal-title":"Heart Rhythm"},{"key":"6709_CR23","doi-asserted-by":"crossref","unstructured":"Bisserier M, Katz MG, Bueno-Beti C, Brojakowska A, Zhang S, Gubara S, Kohlbrenner E, Fazal S, Fargnoli A, Dorfmuller P et al. Combination therapy with STAT3 inhibitor enhances SERCA2a-Induced BMPR2 expression and inhibits pulmonary arterial hypertension. Int J Mol Sci. 2021;22(17).","DOI":"10.3390\/ijms22179105"},{"issue":"6","key":"6709_CR24","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1183\/09031936.00046612","volume":"40","author":"NF Voelkel","year":"2012","unstructured":"Voelkel NF, Gomez-Arroyo J, Abbate A, Bogaard HJ, Nicolls MR. Pathobiology of pulmonary arterial hypertension and right ventricular failure. Eur Respir J. 2012;40(6):1555\u201365.","journal-title":"Eur Respir J"},{"issue":"3","key":"6709_CR25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/ame2.12220","volume":"5","author":"XH Wu","year":"2022","unstructured":"Wu XH, Ma JL, Ding D, Ma YJ, Wei YP, Jing ZC. Experimental animal models of pulmonary hypertension: development and challenges. Anim Model Exp Med. 2022;5(3):207\u201316.","journal-title":"Anim Model Exp Med"},{"key":"6709_CR26","unstructured":"Colvin KL, Yeager ME. Animal models of pulmonary hypertension: matching disease mechanisms to etiology of the human disease. J Pulm Respir Med. 2014;4(4)."},{"key":"6709_CR27","doi-asserted-by":"crossref","unstructured":"Katz MG, Fargnoli AS, Gubara SM, Bisserier M, Sassi Y, Bridges CR, Hajjar RJ, Hadri L. The left pneumonectomy combined with monocrotaline or Sugen as a model of pulmonary hypertension in rats. J Vis Exp. 2019(145).","DOI":"10.3791\/59050-v"},{"issue":"3","key":"6709_CR28","doi-asserted-by":"publisher","first-page":"L229","DOI":"10.1152\/ajplung.00238.2014","volume":"308","author":"SC Pugliese","year":"2015","unstructured":"Pugliese SC, Poth JM, Fini MA, Olschewski A, El Kasmi KC, Stenmark KR. The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes. Am J Physiol Lung Cell Mol Physiol. 2015;308(3):L229\u2013252.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"6709_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0026-2862(89)90017-4","volume":"38","author":"DW Wilson","year":"1989","unstructured":"Wilson DW, Segall HJ, Pan LC, Dunston SK. Progressive inflammatory and structural changes in the pulmonary vasculature of monocrotaline-treated rats. Microvasc Res. 1989;38(1):57\u201380.","journal-title":"Microvasc Res"},{"key":"6709_CR30","doi-asserted-by":"crossref","unstructured":"Krstic AM, Jones TLM, Power AS, Ward ML. The monocrotaline rat model of right heart disease induced by pulmonary artery hypertension. Biomedicines. 2024;12(9).","DOI":"10.3390\/biomedicines12091944"},{"key":"6709_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.pupt.2015.09.007","volume":"35","author":"R Nogueira-Ferreira","year":"2015","unstructured":"Nogueira-Ferreira R, Vitorino R, Ferreira R, Henriques-Coelho T. Exploring the monocrotaline animal model for the study of pulmonary arterial hypertension: a network approach. Pulm Pharmacol Ther. 2015;35:8\u201316.","journal-title":"Pulm Pharmacol Ther"},{"issue":"4","key":"6709_CR32","doi-asserted-by":"publisher","first-page":"L363","DOI":"10.1152\/ajplung.00212.2011","volume":"302","author":"JG Gomez-Arroyo","year":"2012","unstructured":"Gomez-Arroyo JG, Farkas L, Alhussaini AA, Farkas D, Kraskauskas D, Voelkel NF, Bogaard HJ. The monocrotaline model of pulmonary hypertension in perspective. Am J Physiol Lung Cell Mol Physiol. 2012;302(4):L363\u2013369.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"6709_CR33","doi-asserted-by":"publisher","first-page":"L1013","DOI":"10.1152\/ajplung.00217.2009","volume":"297","author":"KR Stenmark","year":"2009","unstructured":"Stenmark KR, Meyrick B, Galie N, Mooi WJ, McMurtry IF. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol. 2009;297(6):L1013\u20131032.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"6709_CR34","doi-asserted-by":"publisher","first-page":"L715","DOI":"10.1152\/ajplung.00086.2009","volume":"297","author":"J Lee","year":"2009","unstructured":"Lee J, Reich R, Xu F, Sehgal PB. Golgi, trafficking, and mitosis dysfunctions in pulmonary arterial endothelial cells exposed to monocrotaline pyrrole and NO scavenging. Am J Physiol Lung Cell Mol Physiol. 2009;297(4):L715\u2013728.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"6709_CR35","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/ATVBAHA.107.141200","volume":"27","author":"RE Morty","year":"2007","unstructured":"Morty RE, Nejman B, Kwapiszewska G, Hecker M, Zakrzewicz A, Kouri FM, Peters DM, Dumitrascu R, Seeger W, Knaus P, et al. Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial hypertension. Arterioscler Thromb Vasc Biol. 2007;27(5):1072\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"6709_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1161\/CIRCULATIONAHA.120.047978","volume":"144","author":"M Bisserier","year":"2021","unstructured":"Bisserier M, Mathiyalagan P, Zhang S, Elmastour F, Dorfm\u00fcller P, Humbert M, David G, Tarzami S, Weber T, Perros F, et al. Regulation of the methylation and expression levels of the BMPR2 gene by SIN3a as a novel therapeutic mechanism in pulmonary arterial hypertension. Circulation. 2021;144(1):52\u201373.","journal-title":"Circulation"},{"issue":"1","key":"6709_CR37","doi-asserted-by":"publisher","first-page":"L1","DOI":"10.1152\/ajplung.00031.2013","volume":"305","author":"MG Dickinson","year":"2013","unstructured":"Dickinson MG, Bartelds B, Borgdorff MA, Berger RM. The role of disturbed blood flow in the development of pulmonary arterial hypertension: lessons from preclinical animal models. Am J Physiol Lung Cell Mol Physiol. 2013;305(1):L1\u201314.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"6709_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2466-8-25","volume":"8","author":"R Dumitrascu","year":"2008","unstructured":"Dumitrascu R, Koebrich S, Dony E, Weissmann N, Savai R, Pullamsetti SS, Ghofrani HA, Samidurai A, Traupe H, Seeger W, et al. Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury. BMC Pulm Med. 2008;8:25.","journal-title":"BMC Pulm Med"},{"issue":"10","key":"6709_CR39","doi-asserted-by":"publisher","first-page":"L977","DOI":"10.1152\/ajplung.00362.2011","volume":"302","author":"J Gomez-Arroyo","year":"2012","unstructured":"Gomez-Arroyo J, Saleem SJ, Mizuno S, Syed AA, Bogaard HJ, Abbate A, Taraseviciene-Stewart L, Sung Y, Kraskauskas D, Farkas D, et al. A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects. Am J Physiol Lung Cell Mol Physiol. 2012;302(10):L977\u2013991.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"6709_CR40","doi-asserted-by":"publisher","first-page":"H1798","DOI":"10.1152\/ajpheart.00654.2011","volume":"301","author":"R Paulin","year":"2011","unstructured":"Paulin R, Meloche J, Jacob MH, Bisserier M, Courboulin A, Bonnet S. Dehydroepiandrosterone inhibits the Src\/STAT3 constitutive activation in pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol. 2011;301(5):H1798\u20131809.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"6709_CR41","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1465-9921-12-128","volume":"12","author":"A Courboulin","year":"2011","unstructured":"Courboulin A, Tremblay VL, Barrier M, Meloche J, Jacob MH, Chapolard M, Bisserier M, Paulin R, Lambert C, Provencher S, et al. Kr\u00fcppel-like factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension. Respir Res. 2011;12(1):128.","journal-title":"Respir Res"},{"issue":"1","key":"6709_CR42","doi-asserted-by":"publisher","first-page":"e005157","DOI":"10.1161\/JAHA.112.005157","volume":"2","author":"J Meloche","year":"2013","unstructured":"Meloche J, Courchesne A, Barrier M, Carter S, Bisserier M, Paulin R, Lauzon-Joset JF, Breuils-Bonnet S, Tremblay \u00c9, Biardel S, et al. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology. J Am Heart Assoc. 2013;2(1):e005157.","journal-title":"J Am Heart Assoc"},{"key":"6709_CR43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.yjmcc.2018.11.017","volume":"127","author":"B Strauss","year":"2019","unstructured":"Strauss B, Sassi Y, Bueno-Beti C, Ilkan Z, Raad N, Cacheux M, Bisserier M, Turnbull IC, Kohlbrenner E, Hajjar RJ, et al. Intra-tracheal gene delivery of aerosolized SERCA2a to the lung suppresses ventricular arrhythmias in a model of pulmonary arterial hypertension. J Mol Cell Cardiol. 2019;127:20\u201330.","journal-title":"J Mol Cell Cardiol"},{"key":"6709_CR44","doi-asserted-by":"crossref","unstructured":"Theofilis P, Sagris M, Oikonomou E, Antonopoulos AS, Siasos G, Tsioufis C, Tousoulis D. Inflammatory mechanisms contributing to endothelial dysfunction. Biomedicines. 2021;9(7).","DOI":"10.3390\/biomedicines9070781"},{"key":"6709_CR45","doi-asserted-by":"publisher","first-page":"873522","DOI":"10.3389\/fphys.2022.873522","volume":"13","author":"LA Barnes","year":"2022","unstructured":"Barnes LA, Mesarwi OA, Sanchez-Azofra A. The cardiovascular and metabolic effects of chronic hypoxia in animal models: a mini-review. Front Physiol. 2022;13:873522.","journal-title":"Front Physiol"},{"issue":"4","key":"6709_CR46","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1086\/678508","volume":"4","author":"SH Vitali","year":"2014","unstructured":"Vitali SH, Hansmann G, Rose C, Fernandez-Gonzalez A, Scheid A, Mitsialis SA, Kourembanas S. The Sugen 5416\/hypoxia mouse model of pulmonary hypertension revisited: long-term follow-up. Pulm Circ. 2014;4(4):619\u201329.","journal-title":"Pulm Circ"},{"issue":"6","key":"6709_CR47","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1172\/JCI11144","volume":"106","author":"NF Voelkel","year":"2000","unstructured":"Voelkel NF, Tuder RM. Hypoxia-induced pulmonary vascular remodeling: a model for what human disease? J Clin Invest. 2000;106(6):733\u20138.","journal-title":"J Clin Invest"},{"issue":"3","key":"6709_CR48","doi-asserted-by":"publisher","first-page":"C555","DOI":"10.1152\/ajpcell.00289.2019","volume":"318","author":"X Wu","year":"2020","unstructured":"Wu X, Lu W, He M, Chen H, Chen Y, Duan X, Zheng Q, Li Y, Chen J, Liu S, et al. Structural and functional definition of the pulmonary vein system in a chronic hypoxia-induced pulmonary hypertension rat model. Am J Physiol Cell Physiol. 2020;318(3):C555\u201369.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6 Suppl","key":"6709_CR49","doi-asserted-by":"publisher","first-page":"s592","DOI":"10.1378\/chest.128.6_suppl.592S","volume":"128","author":"GL Semenza","year":"2005","unstructured":"Semenza GL. Involvement of hypoxia-inducible factor 1 in pulmonary pathophysiology. Chest. 2005;128(6 Suppl):s592\u20134.","journal-title":"Chest"},{"issue":"7","key":"6709_CR50","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1161\/01.RES.0000243584.45145.3f","volume":"99","author":"KR Stenmark","year":"2006","unstructured":"Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res. 2006;99(7):675\u201391.","journal-title":"Circ Res"},{"issue":"6","key":"6709_CR51","first-page":"1119","volume":"37","author":"ED Michelakis","year":"2004","unstructured":"Michelakis ED, Th\u00e9baud B, Weir EK, Archer SL. Hypoxic pulmonary vasoconstriction: redox regulation of O2-sensitive K\u2009+\u2009channels by a mitochondrial O2-sensor in resistance artery smooth muscle cells. J Mol Cell Cardiol. 2004;37(6):1119\u201336.","journal-title":"J Mol Cell Cardiol"},{"issue":"22","key":"6709_CR52","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1161\/CIRCULATIONAHA.105.609008","volume":"113","author":"S Bonnet","year":"2006","unstructured":"Bonnet S, Michelakis ED, Porter CJ, Andrade-Navarro MA, Th\u00e9baud B, Bonnet S, Haromy A, Harry G, Moudgil R, McMurtry MS, et al. An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in Fawn hooded rats: similarities to human pulmonary arterial hypertension. Circulation. 2006;113(22):2630\u201341.","journal-title":"Circulation"},{"issue":"5","key":"6709_CR53","doi-asserted-by":"publisher","first-page":"L782","DOI":"10.1152\/ajplung.00331.2017","volume":"314","author":"JD Marshall","year":"2018","unstructured":"Marshall JD, Bazan I, Zhang Y, Fares WH, Lee PJ. Mitochondrial dysfunction and pulmonary hypertension: cause, effect, or both. Am J Physiol Lung Cell Mol Physiol. 2018;314(5):L782\u201396.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"6709_CR54","doi-asserted-by":"crossref","unstructured":"Harvey LD, Chan SY. Emerging metabolic therapies in pulmonary arterial hypertension. J Clin Med. 2017;6(4).","DOI":"10.3390\/jcm6040043"},{"issue":"15","key":"6709_CR55","doi-asserted-by":"publisher","first-page":"e019488","DOI":"10.1161\/JAHA.120.019488","volume":"10","author":"KR Chaudhary","year":"2021","unstructured":"Chaudhary KR, Deng Y, Yang A, Cober ND, Stewart DJ. Penetrance of severe pulmonary arterial hypertension in response to vascular endothelial growth factor receptor 2 blockade in a genetically prone rat model is reduced by female sex. J Am Heart Assoc. 2021;10(15):e019488.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"6709_CR56","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1165\/rcmb.2017-0435OC","volume":"60","author":"KT Ikeda","year":"2019","unstructured":"Ikeda KT, Hale PT, Pauciulo MW, Dasgupta N, Pastura PA, Le Cras TD, Pandey MK, Nichols WC. Hypoxia-induced pulmonary hypertension in different mouse strains: relation to transcriptome. Am J Respir Cell Mol Biol. 2019;60(1):106\u201316.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"6709_CR57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1165\/rcmb.2018-0307ED","volume":"60","author":"LM Marsh","year":"2019","unstructured":"Marsh LM, Kwapiszewska G. Lessons from transcriptomics in hypoxia-induced pulmonary hypertension: does the mouse strain matter?? Am J Respir Cell Mol Biol. 2019;60(1):13\u20135.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"6709_CR58","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1096\/fj.00-0343com","volume":"15","author":"L Taraseviciene-Stewart","year":"2001","unstructured":"Taraseviciene-Stewart L, Kasahara Y, Alger L, Hirth P, Mc Mahon G, Waltenberger J, Voelkel NF, Tuder RM. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. Faseb J. 2001;15(2):427\u201338.","journal-title":"Faseb J"},{"issue":"1","key":"6709_CR59","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1183\/09031936.00204813","volume":"44","author":"MA de Raaf","year":"2014","unstructured":"de Raaf MA, Schalij I, Gomez-Arroyo J, Rol N, Happ\u00e9 C, de Man FS, Vonk-Noordegraaf A, Westerhof N, Voelkel NF, Bogaard HJ. SuHx rat model: partly reversible pulmonary hypertension and progressive intima obstruction. Eur Respir J. 2014;44(1):160\u20138.","journal-title":"Eur Respir J"},{"issue":"1","key":"6709_CR60","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1161\/CIRCRESAHA.122.321554","volume":"132","author":"I Cuthbertson","year":"2023","unstructured":"Cuthbertson I, Morrell NW, Caruso P. BMPR2 mutation and metabolic reprogramming in pulmonary arterial hypertension. Circ Res. 2023;132(1):109\u201326.","journal-title":"Circ Res"},{"issue":"10","key":"6709_CR61","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1164\/rccm.201103-0412OC","volume":"184","author":"L Ciuclan","year":"2011","unstructured":"Ciuclan L, Bonneau O, Hussey M, Duggan N, Holmes AM, Good R, Stringer R, Jones P, Morrell NW, Jarai G, et al. A novel murine model of severe pulmonary arterial hypertension. Am J Respir Crit Care Med. 2011;184(10):1171\u201382.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"6709_CR62","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1093\/cvr\/cvaa350","volume":"117","author":"BJ Dunmore","year":"2021","unstructured":"Dunmore BJ, Jones RJ, Toshner MR, Upton PD, Morrell NW. Approaches to treat pulmonary arterial hypertension by targeting BMPR2: from cell membrane to nucleus. Cardiovasc Res. 2021;117(11):2309\u201325.","journal-title":"Cardiovasc Res"},{"issue":"7","key":"6709_CR63","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.117.312579","volume":"122","author":"S Provencher","year":"2018","unstructured":"Provencher S, Archer SL, Ramirez FD, Hibbert B, Paulin R, Boucherat O, Lacasse Y, Bonnet S. Standards and methodological rigor in pulmonary arterial hypertension preclinical and translational research. Circ Res. 2018;122(7):1021\u201332.","journal-title":"Circ Res"},{"issue":"5","key":"6709_CR64","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/bph.15444","volume":"179","author":"JP Dignam","year":"2022","unstructured":"Dignam JP, Scott TE, Kemp-Harper BK, Hobbs AJ. Animal models of pulmonary hypertension: getting to the heart of the problem. Br J Pharmacol. 2022;179(5):811\u201337.","journal-title":"Br J Pharmacol"},{"issue":"5","key":"6709_CR65","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.21037\/cdt-20-400","volume":"10","author":"A Andersen","year":"2020","unstructured":"Andersen A, van der Feen DE, Andersen S, Schultz JG, Hansmann G, Bogaard HJ. Animal models of right heart failure. Cardiovasc Diagn Ther. 2020;10(5):1561\u201379.","journal-title":"Cardiovasc Diagn Ther"},{"issue":"2","key":"6709_CR66","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1152\/japplphysiol.00148.2020","volume":"129","author":"Y Akazawa","year":"2020","unstructured":"Akazawa Y, Okumura K, Ishii R, Slorach C, Hui W, Ide H, Honjo O, Sun M, Kabir G, Connelly K, et al. Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension. J Appl Physiol (1985). 2020;129(2):238\u201346.","journal-title":"J Appl Physiol (1985)"},{"key":"6709_CR67","doi-asserted-by":"crossref","unstructured":"Balsa A, Ad\u00e3o R, Br\u00e1s-Silva C. Therapeutic approaches in pulmonary arterial hypertension with beneficial effects on right ventricular Function-Preclinical studies. Int J Mol Sci. 2023;24(21).","DOI":"10.3390\/ijms242115539"},{"key":"6709_CR68","doi-asserted-by":"crossref","unstructured":"Mamazhakypov A, Sommer N, Assmus B, Tello K, Schermuly RT, Kosanovic D, Sarybaev AS, Weissmann N, Pak O. Novel therapeutic targets for the treatment of right ventricular remodeling: insights from the pulmonary artery banding model. Int J Environ Res Public Health. 2021;18(16).","DOI":"10.3390\/ijerph18168297"},{"key":"6709_CR69","doi-asserted-by":"publisher","first-page":"641310","DOI":"10.3389\/fphys.2021.641310","volume":"12","author":"D Sharifi Kia","year":"2021","unstructured":"Sharifi Kia D, Kim K, Simon MA. Current understanding of the right ventricle structure and function in pulmonary arterial hypertension. Front Physiol. 2021;12:641310.","journal-title":"Front Physiol"},{"issue":"3","key":"6709_CR70","doi-asserted-by":"publisher","first-page":"204589401984561","DOI":"10.1177\/2045894019845611","volume":"9","author":"X Ren","year":"2019","unstructured":"Ren X, Johns RA, Gao WD. EXPRESS: right heart in pulmonary hypertension: from adaptation to failure. Pulm Circ. 2019;9(3):2045894019845611.","journal-title":"Pulm Circ"},{"key":"6709_CR71","doi-asserted-by":"crossref","unstructured":"Guignabert C, Aman J, Bonnet S, Dorfm\u00fcller P, Olschewski AJ, Pullamsetti S, Rabinovitch M, Schermuly RT, Humbert M, Stenmark KR. Pathology and pathobiology of pulmonary hypertension: current insights and future directions. Eur Respir J. 2024;64(4).","DOI":"10.1183\/13993003.01095-2024"},{"issue":"1","key":"6709_CR72","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/1465-9921-12-159","volume":"12","author":"Y Dempsie","year":"2011","unstructured":"Dempsie Y, Nilsen M, White K, Mair KM, Loughlin L, Ambartsumian N, Rabinovitch M, Maclean MR. Development of pulmonary arterial hypertension in mice over-expressing S100A4\/Mts1 is specific to females. Respir Res. 2011;12(1):159.","journal-title":"Respir Res"},{"issue":"4","key":"6709_CR73","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1161\/CIRCULATIONAHA.104.492488","volume":"112","author":"Y Song","year":"2005","unstructured":"Song Y, Jones JE, Beppu H, Keaney JF Jr., Loscalzo J, Zhang YY. Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice. Circulation. 2005;112(4):553\u201362.","journal-title":"Circulation"},{"issue":"7","key":"6709_CR74","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nm.3877","volume":"21","author":"L Long","year":"2015","unstructured":"Long L, Ormiston ML, Yang X, Southwood M, Gr\u00e4f S, Machado RD, Mueller M, Kinzel B, Yung LM, Wilkinson JM, et al. Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension. Nat Med. 2015;21(7):777\u201385.","journal-title":"Nat Med"},{"issue":"5","key":"6709_CR75","doi-asserted-by":"publisher","first-page":"L744","DOI":"10.1152\/ajplung.90255.2008","volume":"295","author":"J West","year":"2008","unstructured":"West J, Harral J, Lane K, Deng Y, Ickes B, Crona D, Albu S, Stewart D, Fagan K. Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions. Am J Physiol Lung Cell Mol Physiol. 2008;295(5):L744\u2013755.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"7","key":"6709_CR76","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1161\/CIRCULATIONAHA.118.033744","volume":"139","author":"A Hautefort","year":"2019","unstructured":"Hautefort A, Mendes-Ferreira P, Sabourin J, Manaud G, Bertero T, Rucker-Martin C, Riou M, Ad\u00e3o R, Manoury B, Lambert M, et al. Bmpr2 mutant rats develop pulmonary and cardiac characteristics of pulmonary arterial hypertension. Circulation. 2019;139(7):932\u201348.","journal-title":"Circulation"},{"issue":"23","key":"6709_CR77","doi-asserted-by":"publisher","first-page":"e020451","DOI":"10.1161\/JAHA.120.020451","volume":"10","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zervopoulos SD, Boukouris AE, Lorenzana-Carrillo MA, Saleme B, Webster L, Liu Y, Haromy A, Tabatabaei Dakhili SA, Ussher JR, et al. SNPs for genes encoding the mitochondrial proteins Sirtuin3 and uncoupling protein 2 are associated with disease severity, type 2 diabetes, and outcomes in patients with pulmonary arterial hypertension and this is recapitulated in a new mouse model lacking both genes. J Am Heart Assoc. 2021;10(23):e020451.","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"6709_CR78","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1161\/CIRCULATIONAHA.124.068624","volume":"150","author":"JR Jheng","year":"2024","unstructured":"Jheng JR, Bai Y, Noda K, Huot JR, Cook T, Fisher A, Chen YY, Goncharov DA, Goncharova EA, Simon MA, et al. Skeletal muscle SIRT3 deficiency contributes to pulmonary vascular remodeling in pulmonary hypertension due to heart failure with preserved ejection fraction. Circulation. 2024;150(11):867\u201383.","journal-title":"Circulation"},{"issue":"9","key":"6709_CR79","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1161\/CIRCULATIONAHA.115.014207","volume":"132","author":"F Perros","year":"2015","unstructured":"Perros F, G\u00fcnther S, Ranchoux B, Godinas L, Antigny F, Chaumais MC, Dorfm\u00fcller P, Hautefort A, Raymond N, Savale L, et al. Mitomycin-induced pulmonary veno-occlusive disease: evidence from human disease and animal models. Circulation. 2015;132(9):834\u201347.","journal-title":"Circulation"},{"key":"6709_CR80","first-page":"101437","volume":"34","author":"A Kunadu","year":"2021","unstructured":"Kunadu A, Stalls JS, Labuschagne H, Thayyil A, Falls R, Maddipati V. Mitomycin induced pulmonary veno-occlusive disease. Respir Med Case Rep. 2021;34:101437.","journal-title":"Respir Med Case Rep"},{"issue":"2","key":"6709_CR81","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ajpath.2014.10.021","volume":"185","author":"B Ranchoux","year":"2015","unstructured":"Ranchoux B, G\u00fcnther S, Quarck R, Chaumais MC, Dorfm\u00fcller P, Antigny F, Dumas SJ, Raymond N, Lau E, Savale L, et al. Chemotherapy-induced pulmonary hypertension: role of alkylating agents. Am J Pathol. 2015;185(2):356\u201371.","journal-title":"Am J Pathol"},{"issue":"11","key":"6709_CR82","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.jacbts.2024.04.005","volume":"9","author":"C Becher","year":"2024","unstructured":"Becher C, Wits M, de Man FS, Sanchez-Duffhues G, Goumans MJ. Targeting soluble TGF-\u03b2 factors: advances in precision therapy for pulmonary arterial hypertension. JACC Basic Transl Sci. 2024;9(11):1360\u201374.","journal-title":"JACC Basic Transl Sci"},{"issue":"16","key":"6709_CR83","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1056\/NEJMoa2213558","volume":"388","author":"MM Hoeper","year":"2023","unstructured":"Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, McLaughlin VV, Preston IR, Souza R, Waxman AB, Gr\u00fcnig E, et al. Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension. N Engl J Med. 2023;388(16):1478\u201390.","journal-title":"N Engl J Med"},{"key":"6709_CR84","doi-asserted-by":"crossref","unstructured":"Kelly NJ, Chan SY. Pulmonary arterial hypertension: emerging principles of precision medicine across basic science to clinical practice. Rev Cardiovasc Med. 2022;23(11).","DOI":"10.31083\/j.rcm2311378"},{"issue":"2","key":"6709_CR85","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.chest.2024.02.052","volume":"166","author":"S Sahay","year":"2024","unstructured":"Sahay S, Villasmil Hernandez N, Wang F, Wooten M, Nguyen DT, Fauvel C, Benza R, Graviss EA. Comparison between REVEAL lite 2 and COMPERA 2.0 for risk stratification in pulmonary arterial hypertension. Chest. 2024;166(2):373\u201387.","journal-title":"Chest"},{"issue":"Suppl K","key":"6709_CR86","doi-asserted-by":"publisher","first-page":"K21","DOI":"10.1093\/eurheartj\/suz205","volume":"21","author":"IM Lang","year":"2019","unstructured":"Lang IM, Palazzini M. The burden of comorbidities in pulmonary arterial hypertension. Eur Heart J Suppl. 2019;21(Suppl K):K21\u20138.","journal-title":"Eur Heart J Suppl"},{"issue":"5","key":"6709_CR87","doi-asserted-by":"publisher","first-page":"e014195","DOI":"10.1161\/JAHA.119.014195","volume":"9","author":"RC Frank","year":"2020","unstructured":"Frank RC, Min J, Abdelghany M, Paniagua S, Bhattacharya R, Bhambhani V, Pomerantsev E, Ho JE. Obesity is associated with pulmonary hypertension and modifies outcomes. J Am Heart Assoc. 2020;9(5):e014195.","journal-title":"J Am Heart Assoc"},{"key":"6709_CR88","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.amjcard.2020.07.062","volume":"134","author":"AW Trammell","year":"2020","unstructured":"Trammell AW, Hemnes AR, Tseng V, Shah AJ, Phillips LS, Hart CM. Influence of body weight and diabetes mellitus in patients with pulmonary hypertension. Am J Cardiol. 2020;134:130\u20137.","journal-title":"Am J Cardiol"},{"issue":"9","key":"6709_CR89","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.healun.2024.04.066","volume":"43","author":"I Gialamas","year":"2024","unstructured":"Gialamas I, Arvanitaki A, Rosenkranz S, Wort SJ, R\u00e5degran G, Badagliacca R, Giannakoulas G. The impact of cardiovascular and lung comorbidities in patients with pulmonary arterial hypertension: a systematic review and meta-analysis. J Heart Lung Transpl. 2024;43(9):1383\u201394.","journal-title":"J Heart Lung Transpl"},{"issue":"3","key":"6709_CR90","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.chest.2023.08.023","volume":"165","author":"S Provencher","year":"2024","unstructured":"Provencher S, Mai V, Bonnet S. Managing pulmonary arterial hypertension with cardiopulmonary comorbidities. Chest. 2024;165(3):682\u201391.","journal-title":"Chest"},{"issue":"1","key":"6709_CR91","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1186\/s12933-024-02565-9","volume":"23","author":"A Stepanyan","year":"2024","unstructured":"Stepanyan A, Brojakowska A, Zakharyan R, Hakobyan S, Davitavyan S, Sirunyan T, Khachatryan G, Khlgatian MK, Bisserier M, Zhang S, et al. Evaluating sex-specific responses to western diet across the lifespan: impact on cardiac function and transcriptomic signatures in C57BL\/6J mice at 530 and 640\/750 days of age. Cardiovasc Diabetol. 2024;23(1):454.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"6709_CR92","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.chest.2022.02.041","volume":"162","author":"BE McCarthy","year":"2022","unstructured":"McCarthy BE, McClelland RL, Appleby DH, Moutchia JS, Minhas JK, Min J, Mazurek JA, Smith KA, Fritz JS, Pugliese SC, et al. BMI and treatment response in patients with pulmonary arterial hypertension: a meta-analysis. Chest. 2022;162(2):436\u201347.","journal-title":"Chest"},{"key":"6709_CR93","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.yjmcc.2024.09.002","volume":"196","author":"E Pizzo","year":"2024","unstructured":"Pizzo E, Cervantes DO, Ripa V, Filardo A, Berrettoni S, Ketkar H, Jagana V, Di Stefano V, Singh K, Ezzati A, et al. The cAMP\/PKA signaling pathway conditions cardiac performance in experimental animals with metabolic syndrome. J Mol Cell Cardiol. 2024;196:35\u201351.","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"6709_CR94","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s40200-024-01461-z","volume":"23","author":"SS Bahreiny","year":"2024","unstructured":"Bahreiny SS, Ahangarpour A, Aghaei M, Mohammadpour Fard R, Jalali Far MA, Sakhavarz T. A closer look at Galectin-3: its association with gestational diabetes mellitus revealed by systematic review and meta-analysis. J Diabetes Metab Disord. 2024;23(2):1621\u201333.","journal-title":"J Diabetes Metab Disord"},{"issue":"10","key":"6709_CR95","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1080\/17474086.2024.2391102","volume":"17","author":"Z Eftekhar","year":"2024","unstructured":"Eftekhar Z, Aghaei M, Saki N. DNA damage repair in megakaryopoiesis: molecular and clinical aspects. Expert Rev Hematol. 2024;17(10):705\u201312.","journal-title":"Expert Rev Hematol"},{"key":"6709_CR96","doi-asserted-by":"crossref","unstructured":"Fazal S, Bisserier M, Hadri L. Molecular and genetic profiling for precision medicines in pulmonary arterial hypertension. Cells. 2021;10(3).","DOI":"10.3390\/cells10030638"},{"key":"6709_CR97","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/978-3-031-26625-6_14","volume":"1413","author":"Y Yuan","year":"2023","unstructured":"Yuan Y. Clinical translation of engineered pulmonary vascular models. Adv Exp Med Biol. 2023;1413:273\u201388.","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"6709_CR98","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.stem.2016.08.019","volume":"20","author":"M Gu","year":"2017","unstructured":"Gu M, Shao NY, Sa S, Li D, Termglinchan V, Ameen M, Karakikes I, Sosa G, Grubert F, Lee J, et al. Patient-specific iPSC-derived endothelial cells uncover pathways that protect against pulmonary hypertension in BMPR2 mutation carriers. Cell Stem Cell. 2017;20(4):490\u2013e504495.","journal-title":"Cell Stem Cell"},{"key":"6709_CR99","doi-asserted-by":"publisher","first-page":"115271","DOI":"10.1016\/j.bios.2023.115271","volume":"231","author":"AG Monteduro","year":"2023","unstructured":"Monteduro AG, Rizzato S, Caragnano G, Trapani A, Giannelli G, Maruccio G. Organs-on-chips technologies - a guide from disease models to opportunities for drug development. Biosens Bioelectron. 2023;231:115271.","journal-title":"Biosens Bioelectron"},{"issue":"1","key":"6709_CR100","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/s42003-022-04169-z","volume":"5","author":"AJ Ainscough","year":"2022","unstructured":"Ainscough AJ, Smith TJ, Haensel M, Rhodes CJ, Fellows A, Whitwell HJ, Vasilaki E, Gray K, Freeman A, Howard LS, et al. An organ-on-chip model of pulmonary arterial hypertension identifies a BMPR2-SOX17-prostacyclin signalling axis. Commun Biol. 2022;5(1):1192.","journal-title":"Commun Biol"},{"key":"6709_CR101","doi-asserted-by":"publisher","first-page":"1162889","DOI":"10.3389\/fphar.2023.1162889","volume":"14","author":"M Lam","year":"2023","unstructured":"Lam M, Lamanna E, Organ L, Donovan C, Bourke JE. Perspectives on precision cut lung slices-powerful tools for investigation of mechanisms and therapeutic targets in lung diseases. Front Pharmacol. 2023;14:1162889.","journal-title":"Front Pharmacol"},{"issue":"1","key":"6709_CR102","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1165\/rcmb.2024-0479ST","volume":"72","author":"M Lehmann","year":"2024","unstructured":"Lehmann M, Krishnan R, Sucre J, Kulkarni HS, Pineda RH, Anderson C, Banovich NE, Behrsing HP, Dean CH, Haak A, et al. Precision cut lung slices: emerging tools for preclinical and translational lung research. An official American thoracic society workshop report. Am J Respir Cell Mol Biol. 2024;72(1):16\u201331.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"6709_CR103","doi-asserted-by":"publisher","first-page":"L114","DOI":"10.1152\/ajplung.00293.2022","volume":"325","author":"Y Bai","year":"2023","unstructured":"Bai Y, Li G, Yung L, Yu PB, Ai X. Intrapulmonary arterial contraction assay reveals region-specific deregulation of vasoreactivity to lung injuries. Am J Physiol Lung Cell Mol Physiol. 2023;325(2):L114\u201324.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"6709_CR104","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12931-025-03110-2","volume":"26","author":"C Machahua","year":"2025","unstructured":"Machahua C, Marti TM, Dorn P, Funke-Chambour M. Fibrosis in PCLS: comparing TGF-\u03b2 and fibrotic cocktail. Respir Res. 2025;26(1):44.","journal-title":"Respir Res"},{"issue":"6","key":"6709_CR105","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1165\/rcmb.2019-0276TR","volume":"62","author":"HN Alsafadi","year":"2020","unstructured":"Alsafadi HN, Uhl FE, Pineda RH, Bailey KE, Rojas M, Wagner DE, K\u00f6nigshoff M. Applications and approaches for three-dimensional precision-cut lung slices. Disease modeling and drug discovery. Am J Respir Cell Mol Biol. 2020;62(6):681\u201391.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"6709_CR106","doi-asserted-by":"publisher","first-page":"e12237","DOI":"10.1002\/pul2.12237","volume":"13","author":"B Hyde","year":"2023","unstructured":"Hyde B, Paoli CJ, Panjabi S, Bettencourt KC, Bell Lynum KS, Selej M. A claims-based, machine-learning algorithm to identify patients with pulmonary arterial hypertension. Pulm Circ. 2023;13(2):e12237.","journal-title":"Pulm Circ"},{"key":"6709_CR107","doi-asserted-by":"publisher","first-page":"1422327","DOI":"10.3389\/fcvm.2024.1422327","volume":"11","author":"A Fadilah","year":"2024","unstructured":"Fadilah A, Putri VYS, Puling I, Willyanto SE. Assessing the precision of machine learning for diagnosing pulmonary arterial hypertension: a systematic review and meta-analysis of diagnostic accuracy studies. Front Cardiovasc Med. 2024;11:1422327.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"6709_CR108","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12890-024-02891-4","volume":"24","author":"S Imai","year":"2024","unstructured":"Imai S, Sakao S, Nagata J, Naito A, Sekine A, Sugiura T, Shigeta A, Nishiyama A, Yokota H, Shimizu N, et al. Artificial intelligence-based model for predicting pulmonary arterial hypertension on chest x-ray images. BMC Pulm Med. 2024;24(1):101.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"6709_CR109","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1038\/s41598-023-30503-4","volume":"13","author":"M Mamalakis","year":"2023","unstructured":"Mamalakis M, Dwivedi K, Sharkey M, Alabed S, Kiely D, Swift AJ. A transparent artificial intelligence framework to assess lung disease in pulmonary hypertension. Sci Rep. 2023;13(1):3812.","journal-title":"Sci Rep"},{"issue":"5","key":"6709_CR110","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/MCP.0000000000001103","volume":"30","author":"MJ Sharkey","year":"2024","unstructured":"Sharkey MJ, Checkley EW, Swift AJ. Applications of artificial intelligence in computed tomography imaging for phenotyping pulmonary hypertension. Curr Opin Pulm Med. 2024;30(5):464\u201372.","journal-title":"Curr Opin Pulm Med"},{"key":"6709_CR111","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.csbj.2024.11.031","volume":"24","author":"P Argiento","year":"2024","unstructured":"Argiento P, D\u2019Agostino A, Castaldo R, Franzese M, Mazzola M, Gr\u00fcnig E, Saldamarco L, Valente V, Schiavo A, Maffei E, et al. A pulmonary hypertension targeted algorithm to improve referral to right heart catheterization: a machine learning approach. Comput Struct Biotechnol J. 2024;24:746\u201353.","journal-title":"Comput Struct Biotechnol J"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06709-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06709-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06709-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T12:03:38Z","timestamp":1750161818000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06709-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":111,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6709"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06709-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"9 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, as it did not involve human participants or animal subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study was exempt from ethical review as it did not involve individual data requiring consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"665"}}